Under construction – not a live service
Sign in
Not yet taking people in JapanNo phase

Nurse-led inhaler teaching for sleep in people with COPD

Tests nurse-led inhaler teaching to see if it improves sleep in adults with COPD.

Plain-language title generated from the registry record
Registry title: Improvement of Sleep in COPD Patients Through Inhalation Management Education by Nurse.

Key facts

Where
Kumamoto, JapanSee the site

Where in Japan

  • Kumamoto UniversityKumamoto, JapanNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Kumamoto University
Trial code
NCT07311499
Record updated
31 December 2025
Original description
This study aims to investigate whether inhalation management education provided by nurses improves sleep quality in patients with COPD. Inhalation management education includes training in inhalation techniques and guidance on how to use medications when symptoms occur.Read full original descriptionShow less

A Study on Improving Sleep Quality in COPD Patients Through Inhalation Management Education by Nurses Using Video Conferencing Tools.

This study aims to investigate whether inhalation management education provided by nurses improves sleep quality in patients with COPD. Inhalation management education includes training in inhalation techniques and guidance on how to use medications when symptoms occur.

The main research question is:

・Does inhalation management education improve sleep quality in patients with COPD?

Researchers will determine whether inhalation management education improves sleep quality compared to no education.

Participants will:

* Participate in two interviews with researchers using video conferencing tools. * Keep a diary recording their symptoms, sleep duration, and the frequency of rescue inhaler use.

Inclusion: Individuals aged 20 years or older at the time of consent; Individuals who have been prescribed inhaled medications and have been using them continuously for more than one month; Prior experience with inhalation instruction is not required; Individuals who have not been hospitalized within one month prior to study participation due to exacerbation of COPD; Individuals with obstructive sleep apnea syndrome (OSAS) who are receiving treatment with continuous positive airway pressure (CPAP) therapy are eligible, provided that the physician determines that symptoms are stable following CPAP initiation; Participants must be able to operate devices such as Android, iPad, or computer. However, if a caregiver can operate the device, the participant's inability to do so is acceptable; Participants must be in a stable condition as determined by a physician and have obtained permission to participate.

Exclusion: Suffering from other respiratory diseases such as asthma or interstitial pneumonia; Suffering from advanced cancer, including lung cancer; Suffering from diseases that cause respiratory distress, such as heart disease; Diagnosed with dementia or mental illness; Restricted chest movement due to chest deformity or trauma; Suffering from sleep-disordered breathing with a central AHI of more than 50%.

ClinicalTrials.gov NCT07311499